(Q38144610)

29 August 2017

1 reference

title

Current therapy of peripheral obstructive arterial disease. The non-surgical approach (English)

1 reference

29 August 2017

M De Felice

1

1 reference

29 August 2017

P Gallo

series ordinal

2

1 reference

29 August 2017

G Masotti

series ordinal

3

1 reference

29 August 2017

1 January 1990

1 reference

29 August 2017

1 reference

29 August 2017

41

1 reference

29 August 2017

1-11

1 reference

29 August 2017

1

1 reference

β-Thromboglobulin, Platelet Production Time and Platelet Function in Vascular Disease

29 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Intermittent claudication: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Intermittent claudication. Incidence in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Hemodilution (HD) in patients with ischemic skin ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Selective Clot Lysis with Low-Dose Streptokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

Drug therapy: vasodilator drugs in peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979004100101

10.1177/000331979004100101

21 January 2018

Identifiers

DOI

0 references

1 reference